These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6359384

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S, Arakawa S, Fujii A, Kataoka N, Umezu K, Ishigami J, Hirooka K, Shimatani N, Matsushita M, Hikosaka K.
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Cefaclor in the treatment of respiratory tract infections in children].
    Klech H, Stur O, Götz M.
    Padiatr Padol; 1985 Oct; 20(3):297-306. PubMed ID: 4034220
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.
    Rotschafer J, Crossley K, Zaske D, Viste R.
    Urology; 1979 Sep; 14(3):233-6. PubMed ID: 384643
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
    Kobayashi H, Kawai S, Saito A, Yajima O, Tomizawa M, Nakayama I, Ishikawa K, Tamura M, Ito T, Takeuchi K.
    Kansenshogaku Zasshi; 1986 Sep; 60(9):1052-77. PubMed ID: 3100702
    [No Abstract] [Full Text] [Related]

  • 32. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S, Yokoyama Y, Kikuiri T, Murakami T, Nishihara H, Shimizu T, Abe M, Kurihara Y, Itoh C, Takeuchi K.
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
    Horii M, Morinaga T, Takeuchi T, Shimada S, Yamanaka H, Nishimura T, Noshi Y, Okada T, Sasaki T, Takada S.
    Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
    Hara K, Saito A, Izumikawa K, Yamaguchi K, Suzuyama Y, Shigeno Y, Watanabe K, Komori M, Yamashita K, Miyazaki Y.
    Kansenshogaku Zasshi; 1984 Oct; 58(10):1046-72. PubMed ID: 6442319
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
    Smialowicz CR.
    Clin Ther; 1982 Oct; 5(2):113-9. PubMed ID: 7159894
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of urinary tract infections by cefaclor, with special reference to the antibody-coated bacteria (ACB) detected by the immunoenzyme technique].
    Yamamoto M, Murase T, Taguchi J, Miyake K.
    Hinyokika Kiyo; 1983 Aug; 29(8):959-68. PubMed ID: 6426273
    [Abstract] [Full Text] [Related]

  • 40. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
    Iravani A, Richard GA.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):107-11. PubMed ID: 3524418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.